Agena Bioscience provides a cost-effective solution for pharmacogenetic testing (PGx) with a friendly workflow. The high multiplexing capability of the MassARRAY® System enables simultaneous testing of key pharmacogenetic SNPs, INDELs, and CNVs in a single reaction.
Agena Bioscience has developed over 350 assays to identify actionable polymorphisms and copy number variations (CNVs) affecting genes involved in drug distribution, efficacy, metabolism, and toxicity. Analysis is simple with the PGx reporting tool, which automaticallygenerates haplotypes from the genotype results. Take a look on our pharmacogenetics commercial panels.
